Thursday, Dec 02, 2021
Focus on the big picture

Early results show COVID-19 pill by Chinese company can greatly lower hospitalization risk and death

CGTN, 24 Nov 2021
For more:
https://news.cgtn.com/news/2021-11-24/Early-tests-of-COVID-19-pill-by-Chinese-firm-show-promising-results-15rV4XGImdy/index.html

A #Chinese drugmaker is reporting positive test results for its COVID-19 pill. Early data from trials in Brazil appear promising, while more information is expected in the coming month. Suzhou-based Kintor Pharma started to develop the drug shortly after the initial outbreak last year. Proxalutamide is the only small-molecule oral drug treatment for #COVID-19 inpatients which has entered phase III multiregional clinical trials.

Subscribe to us on YouTube: https://goo.gl/lP12gA
Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8
Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv
Related Articles